Genetically engineered microorganism capable of growing on formate, methanol, methane or CO2
Inventors
Bar-Even, Arren • Yishai, Oren • KIM, Seohyoung
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
The present invention relates to a genetically engineered microorganism expressing (i) formate tetrahydrofolate (THF) ligase, methenyi-THF cyclohydrolase and methylene-THF dehydrogenase, (ii) the enzymes of the glycine cleavage system (GCS), (iii) serine deaminase and serine hydroxymethyltransferase (SHMT), (iv) an enzyme increasing the availability of NADPH, and (v) optionally formate dehydrogenase (FDH), and wherein the genetically engineered microorganism has been genetically engineered to express at least one of the enzymes of (i) to (v), wheren said enzyme is not expressed by the corresponding microorganism that has been used to prepare the genetically engineered microorganism, and wherein the enzymes of (i) to (v) are genomically expressed.
Core Innovation
The invention relates to a genetically engineered microorganism that enables aerobic growth on C1 feedstocks and supports carbon assimilation through a designed reductive glycine pathway (rGlyP). The engineered microorganism includes enzymes of a formate tetrahydrofolate (THF) ligase pathway module, enzymes of a glycine cleavage system (GCS) module, and enzymes of a serine deaminase and serine hydroxymethyltransferase (SHMT) step. The pathway is described as a modular, linear synthetic route that supports flux consistent with rGlyP.
The invention further incorporates an enzyme increasing the availability of NADPH, with membrane transhydrogenase (PntAB) and other NADPH-increasing enzymes mentioned as options. In addition, a formate dehydrogenase (FDH) component is included as part of the engineered system. The document describes a genetically engineered strain that initially can grow on formate as sole carbon/energy only after modular genomic overexpression, including FDH, and that achieves improved growth behavior after short-term evolution.
The described improvements are supported by reported results including 13C/CO2 labeling consistent with rGlyP flux, and the concept is extended to methanol assimilation via a NAD-dependent methanol dehydrogenase with growth confirmed by labeling. The document also describes genomic expression control using safe spots, strong constitutive promoters, and modified ribosome binding sites (RBS), along with reported evolutionary changes linked to increased FDH expression and increased NADPH availability enzyme expression.
Claims Coverage
The partial claim set provided indicates one independent claim, with dependent claims refining organism type and specific expression/tuning elements. The main inventive features center on expressing a modular rGlyP enzyme set with formate-THF ligase pathway components, glycine cleavage system (GCS) enzymes, serine deaminase and SHMT, a selected NADPH availability enzyme, and FDH, with expression driven by strong constitutive promoters and/or modified RBS to achieve robust overexpression.
Modular rGlyP enzyme set with NADPH availability and FDH
A genetically engineered microorganism expressing a formate tetrahydrofolate (THF) ligase, a methenyl-THF cyclohydrolase, a methylene-THF dehydrogenase, enzymes of a glycine cleavage system (GCS), a serine deaminase and a serine hydroxymethyltransferase (SHMT), an enzyme increasing the availability of NADPH selected from membrane transhydrogenase (PntAB), glucose 6-phosphate dehydrogenase (Zwf), 6-phosphogluconate dehydrogenase (Gnd), malic B enzyme (MaeB), and isocitrate dehydrogenase (Icd), and a formate dehydrogenase (FDH).
Genomically expressed under strong constitutive promoter or modified RBS for robust overexpression
The enzymes are genomically expressed under the control of a strong constitutive promoter that leads to robust overexpression of genes encoding the enzymes and/or a modified ribosome binding site (RBS) that increases the translation initiation rate and protein abundance compared with a corresponding wild-type RBS.
NADPH availability enzyme specified as a selected set member
The enzyme increasing the availability of NADPH is selected from membrane transhydrogenase (PntAB), glucose 6-phosphate dehydrogenase (Zwf), 6-phosphogluconate dehydrogenase (Gnd), malic B enzyme (MaeB), and isocitrate dehydrogenase (Icd).
FDH included as a required expressed component
The genetically engineered microorganism expresses a formate dehydrogenase (FDH) as part of the enzyme set expressed for the engineered pathway.
The claim coverage focuses on a genetically engineered microorganism expressing a specific modular set of enzymes for a formate-THF/GCS/serine-enzymatic route, together with a defined NADPH availability enzyme and FDH, with robust overexpression driven by strong constitutive promoters and/or modified RBS.
Stated Advantages
Enables robust overexpression of genes encoding the enzymes and/or increased protein abundance via modified translation initiation rate.
Supports improved growth performance described as growth on formate as sole carbon/energy after modular genomic overexpression, and improved growth after short-term evolution.
Provides mechanistic consistency with rGlyP flux using 13C/CO2 labeling.
Extends the concept to methanol assimilation with growth confirmed by labeling.
Documented Applications
Aerobic growth supported on C1 feedstocks including formate, methanol, methane, and CO2, using the designed reductive glycine pathway (rGlyP).
Methanol assimilation using a NAD-dependent methanol dehydrogenase with growth confirmed by labeling.
CO2 to formate conversion is described in dependent claim refinement and associated with the engineered enzyme system.
Interested in licensing this patent?